Patents by Inventor Patricia Cogram

Patricia Cogram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132511
    Abstract: The present disclosure generally relates to methods of and uses for treating Prader-Willi Syndrome (PWS) in a subject, comprising administering to the subject a therapeutically effective amount of a compound of Formulas I, II, III or IV, or a pharmaceutically acceptable salt, hydrate, stereoisomer, or prodrug thereof, or for use in the manufacture of a medicament as described herein.
    Type: Application
    Filed: February 11, 2022
    Publication date: April 25, 2024
    Inventors: Lawrence Irwin GLASS, Patricia COGRAM
  • Publication number: 20230301994
    Abstract: Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well as manufacture of compositions, medicaments including tablets, capsules, liquid formulations, gels, injectable solutions, and other formulations that are useful for treatment of such conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: September 28, 2023
    Inventors: Patricia COGRAM, Jonathan PILCHER, Lawrence Irwin GLASS
  • Publication number: 20230270752
    Abstract: Methods for treating Phelan McDermid Syndrome (PMS) in subjects having the disorder or in subjects predisposed to develop the disorder via administration of farnesyl dibenzodiazepinone compounds are provided. The use of farnesyl dibenzodiazepinone compounds in the manufacture of a medicament for treating a subject having PMS is provided as well.
    Type: Application
    Filed: April 14, 2023
    Publication date: August 31, 2023
    Applicant: AMO Pharma Ltd.
    Inventors: Michael Snape, Patricia Cogram, Robert Deacon
  • Publication number: 20220387426
    Abstract: Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well as manufacture of compositions, medicaments including tablets, capsules, liquid formulations, gels, injectable solutions, and other formulations that are useful for treatment of such conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: December 8, 2022
    Inventors: Patricia COGRAM, Jonathan PILCHER, Lawrence Irwin GLASS
  • Patent number: 11197856
    Abstract: Embodiments of this invention provide compositions and methods for therapeutic use of diketopiperazines including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat symptoms of Autistic Disorder or Autism, as well as manufacture of medicaments including tablets, capsules, liquid formulations, gels, injectable solutions, and other formulations that are useful for treatment of such conditions.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: December 14, 2021
    Assignee: NEUREN PHARMACEUTICALS LIMITED
    Inventors: Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, Patricia Cogram
  • Publication number: 20200330478
    Abstract: Methods for treating Phelan McDermid Syndrome (PMS) in subjects having the disorder or in subjects predisposed to develop the disorder via administration of farnesyl dibenzodiazepinone compounds are provided. The use of farnesyl dibenzodiazepinone compounds in the manufacture of a medicament for treating a subject having PMS is provided as well.
    Type: Application
    Filed: October 25, 2018
    Publication date: October 22, 2020
    Applicant: AMO Pharma Ltd.
    Inventors: Michael Snape, Patricia Cogram, Robert Deacon
  • Publication number: 20200163961
    Abstract: Embodiments of this invention provide compositions and methods for therapeutic use of diketopiperazines including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat symptoms of Autistic Disorder or Autism, as well as manufacture of medicaments including tablets, capsules, liquid formulations, gels, injectable solutions, and other formulations that are useful for treatment of such conditions.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 28, 2020
    Inventors: Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, Patricia Cogram